Not Signed In - Replidyne Phase II Pediatric Trial Meets Primary Objective
Wed, 07 Mar 2007 08:00 AM EST
... Replidyne, Inc. (Nasdaq: RDYN) announced today that it has completed its Phase II clinical trial using faropenem medoxomil (faropenem) in pediatric patients with acute otitis media (AOM), a common infection of the middle ear. [click link for full article] ...
Related Topics
- Clinical Trials
- Primary
- Primary Care
- Pediatric Care
- Children's Health
- Pulmonary Hypertension
- Pediatric Aids
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Cirrhosis (Primary Biliary)
- Primary Biliary Cirrhosis
- Autoimmune Disorders
- Primary hyperoxaluria
- Biliary Cirrhosis
- Crohn's Disease
- Lymphedema
- Kniest dysplasia
- Didanosine Pediatric Oral Solution
- Primary Sclerosing Cholangitis
email this page
print this page
bookmark this page
feedback on this page
